The Yablonskiy Lab is focused on developing new quantitative MRI-based methods for in vivo studying of humans and animals in health and disease. Recent work is concentrated on applying MRI-based Gradient Echo Plural Contrast Imaging (GEPCI) and its advanced version quantitative Gradient Recalled Echo (qGRE) techniques – developed by the lab – to link brain genetic and cellular microstructure with brain functioning in healthy people and patients with brain diseases, including Alzheimer’s disease, multiple sclerosis and amyotrophic lateral sclerosis.